Global Bovine Blood Plasma Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.

According to APO Research, The global Bovine Blood Plasma Derivatives market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bovine Blood Plasma Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bovine Blood Plasma Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Bovine Blood Plasma Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Bovine Blood Plasma Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bovine Blood Plasma Derivatives include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen and Biowest, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Bovine Blood Plasma Derivatives production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Bovine Blood Plasma Derivatives by region (region level and country level), by company, by type and by application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Bovine Blood Plasma Derivatives, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Bovine Blood Plasma Derivatives, also provides the consumption of main regions and countries. Of the upcoming market potential for Bovine Blood Plasma Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bovine Blood Plasma Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Bovine Blood Plasma Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Bovine Blood Plasma Derivatives sales, projected growth trends, production technology, application and end-user industry.


Bovine Blood Plasma Derivatives Segment by Company

Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac

Bovine Blood Plasma Derivatives Segment by Type

Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other

Bovine Blood Plasma Derivatives Segment by Application

Scientific Research
Industrial Production
Feed
Others

Bovine Blood Plasma Derivatives Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Plasma Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bovine Blood Plasma Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Plasma Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bovine Blood Plasma Derivatives market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bovine Blood Plasma Derivatives industry.
Chapter 3: Detailed analysis of Bovine Blood Plasma Derivatives market competition landscape. Including Bovine Blood Plasma Derivatives manufacturers' output value, output and average price from 2020 to 2025, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Bovine Blood Plasma Derivatives by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Bovine Blood Plasma Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2020-2031)
1.2.2 Global Bovine Blood Plasma Derivatives Production Capacity Estimates and Forecasts (2020-2031)
1.2.3 Global Bovine Blood Plasma Derivatives Production Estimates and Forecasts (2020-2031)
1.2.4 Global Bovine Blood Plasma Derivatives Market Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Global Bovine Blood Plasma Derivatives Market Dynamics
2.1 Bovine Blood Plasma Derivatives Industry Trends
2.2 Bovine Blood Plasma Derivatives Industry Drivers
2.3 Bovine Blood Plasma Derivatives Industry Opportunities and Challenges
2.4 Bovine Blood Plasma Derivatives Industry Restraints
3 Bovine Blood Plasma Derivatives Market by Manufacturers
3.1 Global Bovine Blood Plasma Derivatives Production Value by Manufacturers (2020-2025)
3.2 Global Bovine Blood Plasma Derivatives Production by Manufacturers (2020-2025)
3.3 Global Bovine Blood Plasma Derivatives Average Price by Manufacturers (2020-2025)
3.4 Global Bovine Blood Plasma Derivatives Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Bovine Blood Plasma Derivatives Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Bovine Blood Plasma Derivatives Manufacturers, Product Type & Application
3.7 Global Bovine Blood Plasma Derivatives Manufacturers Established Date
3.8 Market Competitive Analysis
3.8.1 Global Bovine Blood Plasma Derivatives Market CR5 and HHI
3.8.2 Global Top 5 and 10 Bovine Blood Plasma Derivatives Players Market Share by Production Value in 2024
3.8.3 2024 Bovine Blood Plasma Derivatives Tier 1, Tier 2, and Tier 3
4 Bovine Blood Plasma Derivatives Market by Type
4.1 Bovine Blood Plasma Derivatives Type Introduction
4.1.1 Bovine Serum
4.1.2 FBS
4.1.3 Bovine Serum Albumin
4.1.4 Fibrinogen
4.1.5 Protein Ingredient
4.1.6 Other
4.2 Global Bovine Blood Plasma Derivatives Production by Type
4.2.1 Global Bovine Blood Plasma Derivatives Production by Type (2020 VS 2024 VS 2031)
4.2.2 Global Bovine Blood Plasma Derivatives Production by Type (2020-2031)
4.2.3 Global Bovine Blood Plasma Derivatives Production Market Share by Type (2020-2031)
4.3 Global Bovine Blood Plasma Derivatives Production Value by Type
4.3.1 Global Bovine Blood Plasma Derivatives Production Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Bovine Blood Plasma Derivatives Production Value by Type (2020-2031)
4.3.3 Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2020-2031)
5 Bovine Blood Plasma Derivatives Market by Application
5.1 Bovine Blood Plasma Derivatives Application Introduction
5.1.1 Scientific Research
5.1.2 Industrial Production
5.1.3 Feed
5.1.4 Others
5.2 Global Bovine Blood Plasma Derivatives Production by Application
5.2.1 Global Bovine Blood Plasma Derivatives Production by Application (2020 VS 2024 VS 2031)
5.2.2 Global Bovine Blood Plasma Derivatives Production by Application (2020-2031)
5.2.3 Global Bovine Blood Plasma Derivatives Production Market Share by Application (2020-2031)
5.3 Global Bovine Blood Plasma Derivatives Production Value by Application
5.3.1 Global Bovine Blood Plasma Derivatives Production Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Bovine Blood Plasma Derivatives Production Value by Application (2020-2031)
5.3.3 Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2020-2031)
6 Company Profiles
6.1 Thermo Fisher
6.1.1 Thermo Fisher Comapny Information
6.1.2 Thermo Fisher Business Overview
6.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Product Portfolio
6.1.5 Thermo Fisher Recent Developments
6.2 GE Healthcare
6.2.1 GE Healthcare Comapny Information
6.2.2 GE Healthcare Business Overview
6.2.3 GE Healthcare Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.2.4 GE Healthcare Bovine Blood Plasma Derivatives Product Portfolio
6.2.5 GE Healthcare Recent Developments
6.3 Merck (Sigma-Aldrich)
6.3.1 Merck (Sigma-Aldrich) Comapny Information
6.3.2 Merck (Sigma-Aldrich) Business Overview
6.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Portfolio
6.3.5 Merck (Sigma-Aldrich) Recent Developments
6.4 Moregate BioTech
6.4.1 Moregate BioTech Comapny Information
6.4.2 Moregate BioTech Business Overview
6.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Product Portfolio
6.4.5 Moregate BioTech Recent Developments
6.5 Gemini
6.5.1 Gemini Comapny Information
6.5.2 Gemini Business Overview
6.5.3 Gemini Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.5.4 Gemini Bovine Blood Plasma Derivatives Product Portfolio
6.5.5 Gemini Recent Developments
6.6 Atlanta Biologicals
6.6.1 Atlanta Biologicals Comapny Information
6.6.2 Atlanta Biologicals Business Overview
6.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Product Portfolio
6.6.5 Atlanta Biologicals Recent Developments
6.7 Tissue Culture Biologicals
6.7.1 Tissue Culture Biologicals Comapny Information
6.7.2 Tissue Culture Biologicals Business Overview
6.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Portfolio
6.7.5 Tissue Culture Biologicals Recent Developments
6.8 Bovogen
6.8.1 Bovogen Comapny Information
6.8.2 Bovogen Business Overview
6.8.3 Bovogen Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.8.4 Bovogen Bovine Blood Plasma Derivatives Product Portfolio
6.8.5 Bovogen Recent Developments
6.9 Biowest
6.9.1 Biowest Comapny Information
6.9.2 Biowest Business Overview
6.9.3 Biowest Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.9.4 Biowest Bovine Blood Plasma Derivatives Product Portfolio
6.9.5 Biowest Recent Developments
6.10 Internegocios
6.10.1 Internegocios Comapny Information
6.10.2 Internegocios Business Overview
6.10.3 Internegocios Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.10.4 Internegocios Bovine Blood Plasma Derivatives Product Portfolio
6.10.5 Internegocios Recent Developments
6.11 RMBIO
6.11.1 RMBIO Comapny Information
6.11.2 RMBIO Business Overview
6.11.3 RMBIO Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.11.4 RMBIO Bovine Blood Plasma Derivatives Product Portfolio
6.11.5 RMBIO Recent Developments
6.12 Biological Industries
6.12.1 Biological Industries Comapny Information
6.12.2 Biological Industries Business Overview
6.12.3 Biological Industries Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.12.4 Biological Industries Bovine Blood Plasma Derivatives Product Portfolio
6.12.5 Biological Industries Recent Developments
6.13 VWR
6.13.1 VWR Comapny Information
6.13.2 VWR Business Overview
6.13.3 VWR Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.13.4 VWR Bovine Blood Plasma Derivatives Product Portfolio
6.13.5 VWR Recent Developments
6.14 Corning
6.14.1 Corning Comapny Information
6.14.2 Corning Business Overview
6.14.3 Corning Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.14.4 Corning Bovine Blood Plasma Derivatives Product Portfolio
6.14.5 Corning Recent Developments
6.15 Serana
6.15.1 Serana Comapny Information
6.15.2 Serana Business Overview
6.15.3 Serana Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.15.4 Serana Bovine Blood Plasma Derivatives Product Portfolio
6.15.5 Serana Recent Developments
6.16 Lanzhou Minhai
6.16.1 Lanzhou Minhai Comapny Information
6.16.2 Lanzhou Minhai Business Overview
6.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Product Portfolio
6.16.5 Lanzhou Minhai Recent Developments
6.17 Zhejiang Tianhang Biotechnology
6.17.1 Zhejiang Tianhang Biotechnology Comapny Information
6.17.2 Zhejiang Tianhang Biotechnology Business Overview
6.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Portfolio
6.17.5 Zhejiang Tianhang Biotechnology Recent Developments
6.18 ExCell Bio
6.18.1 ExCell Bio Comapny Information
6.18.2 ExCell Bio Business Overview
6.18.3 ExCell Bio Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.18.4 ExCell Bio Bovine Blood Plasma Derivatives Product Portfolio
6.18.5 ExCell Bio Recent Developments
6.19 Jin Yuan Kang
6.19.1 Jin Yuan Kang Comapny Information
6.19.2 Jin Yuan Kang Business Overview
6.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Product Portfolio
6.19.5 Jin Yuan Kang Recent Developments
6.20 American Protein Company
6.20.1 American Protein Company Comapny Information
6.20.2 American Protein Company Business Overview
6.20.3 American Protein Company Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.20.4 American Protein Company Bovine Blood Plasma Derivatives Product Portfolio
6.20.5 American Protein Company Recent Developments
6.21 Sonac
6.21.1 Sonac Comapny Information
6.21.2 Sonac Business Overview
6.21.3 Sonac Bovine Blood Plasma Derivatives Production, Value and Gross Margin (2020-2025)
6.21.4 Sonac Bovine Blood Plasma Derivatives Product Portfolio
6.21.5 Sonac Recent Developments
7 Global Bovine Blood Plasma Derivatives Production by Region
7.1 Global Bovine Blood Plasma Derivatives Production by Region: 2020 VS 2024 VS 2031
7.2 Global Bovine Blood Plasma Derivatives Production by Region (2020-2031)
7.2.1 Global Bovine Blood Plasma Derivatives Production by Region: 2020-2025
7.2.2 Global Bovine Blood Plasma Derivatives Production Forecast by Region: 2026-2031
7.3 Global Bovine Blood Plasma Derivatives Production by Region: 2020 VS 2024 VS 2031
7.4 Global Bovine Blood Plasma Derivatives Production Value by Region (2020-2031)
7.4.1 Global Bovine Blood Plasma Derivatives Production Value by Region: 2020-2025
7.4.2 Global Bovine Blood Plasma Derivatives Production Value by Region (2026-2031)
7.5 Global Bovine Blood Plasma Derivatives Market Price Analysis by Region (2020-2031)
7.6 Regional Production Value Trends (2020-2031)
7.6.1 North America Bovine Blood Plasma Derivatives Production Value (2020-2031)
7.6.2 Europe Bovine Blood Plasma Derivatives Production Value (2020-2031)
7.6.3 Asia-Pacific Bovine Blood Plasma Derivatives Production Value (2020-2031)
7.6.4 South America Bovine Blood Plasma Derivatives Production Value (2020-2031)
7.6.5 Middle East & Africa Bovine Blood Plasma Derivatives Production Value (2020-2031)
8 Global Bovine Blood Plasma Derivatives Consumption by Region
8.1 Global Bovine Blood Plasma Derivatives Consumption by Region: 2020 VS 2024 VS 2031
8.2 Global Bovine Blood Plasma Derivatives Consumption by Region (2020-2031)
8.2.1 Global Bovine Blood Plasma Derivatives Consumption by Region (2020-2025)
8.2.2 Global Bovine Blood Plasma Derivatives Consumption by Region (2026-2031)
8.3 North America
8.3.1 North America Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.3.2 North America Bovine Blood Plasma Derivatives Consumption by Country (2020-2031)
8.3.3 U.S.
8.3.4 Canada
8.3.5 Mexico
8.4 Europe
8.4.1 Europe Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.4.2 Europe Bovine Blood Plasma Derivatives Consumption by Country (2020-2031)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.5.2 Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2020-2031)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 South America
8.6.1 South America Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.6.2 South America Bovine Blood Plasma Derivatives Consumption by Country (2020-2031)
8.6.3 Brazil
8.6.4 Argentina
8.6.5 Chile
8.6.6 Colombia
8.7 Middle East & Africa
8.7.1 Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.7.2 Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2020-2031)
8.7.3 Egypt
8.7.4 South Africa
8.7.5 Israel
8.7.6 Türkiye
8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
9.1 Bovine Blood Plasma Derivatives Value Chain Analysis
9.1.1 Bovine Blood Plasma Derivatives Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Bovine Blood Plasma Derivatives Production Mode & Process
9.2 Bovine Blood Plasma Derivatives Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Bovine Blood Plasma Derivatives Distributors
9.2.3 Bovine Blood Plasma Derivatives Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings